Home
Contact
✕
Editorials
Home
Editorials
Filter by
Categories
Tags
Authors
Show all
All
Editorials
New Trials
Ongoing Trials
Trial Results
Uncategorized
All
Acute lymphoblastic leukemia
Adolescents and young adults
Anal cancer
Antioxidants
Blood cancers
Breast cancer
Cancer care delivery
Caregiving
Chemotherapy
Chronic lymphocytic leukemia
Communication
COVID-19
De-escalation
Esophagus cancer
GI cancer
Green tea
Head and neck cancer
Health equity
HER2+ breast cancer
Hormone therapy
Immune system therapy
Immunotherapy
In memory
Kidney cancer
Language
Late Effects
Leukemia
Lung cancer
Lymphoma
Mammography
Mantle cell lymphoma
Melanoma
Mesothelioma
Minimal residual disease
MRI
Multiple myeloma
Myeloma
NCI-MATCH
Neuropathy
Older adults
Pancreatic cancer
Pancreatic cysts
Patient-reported outcomes
Personalized medicine
Personalized screening
Personalized treatment
Precision medicine
Prevention
Prostate cancer
Renal cell carcinoma
Screening
Side effects
Squamous cell carcinoma
Surveillance
Survivorship
Targeted therapy
Throat cancer
Triple-negative breast cancer
Tumor test
All
Diane Dragaud
ecogacrinnews2
Katie Heller
June 28, 2022
June 28, 2022
Categories
Editorials
Unconscious Bias Among Physicians Creates Obstacles to Genetic Counseling and Testing For Black Women with Breast Cancer
A nationwide survey found that doctors’ beliefs and practices regarding genetic counseling and testing varied by race
March 24, 2022
March 24, 2022
Categories
Editorials
Come Again? Communicating Clearly About Risk of Recurrence After Early-Stage Breast Cancer
Mary Lou Smith and colleagues at the Research Advocacy Network recently explored how well patients with early-stage breast cancer understand risk of their cancer coming back
September 20, 2021
September 20, 2021
Categories
Editorials
The Language of (Lung) Cancer
A new language guide encourages respect, eliminates blame, and promotes health equity
June 24, 2021
June 24, 2021
Categories
Editorials
Advocacy and the NCI’s National Clinical Trials Network
Advocates play an important role in each of the NCTN groups, helping to inform the design and implementation of clinical trials
1
2
3
4
Next page